HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Seock-Ah Im Selected Research

orantinib (SU6668)

12/2017Quality of life on TSU-68: Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline.
4/2016Circulating Plasma Biomarkers for TSU-68, an Oral Antiangiogenic Agent, in Patients with Metastatic Breast Cancer.
8/2014Combination of docetaxel and TSU-68, an oral antiangiogenic agent, in patients with metastatic breast cancer previously treated with anthracycline: randomized phase II multicenter trial.
2/2012Augmentation of chemotherapeutic infusion effect by TSU-68, an oral targeted antiangiogenic agent, in a rabbit VX2 liver tumor model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Seock-Ah Im Research Topics

Disease

203Breast Neoplasms (Breast Cancer)
10/2022 - 12/2004
169Neoplasms (Cancer)
10/2022 - 12/2004
56Stomach Neoplasms (Stomach Cancer)
10/2021 - 11/2004
34Neoplasm Metastasis (Metastasis)
12/2021 - 06/2005
28Triple Negative Breast Neoplasms
10/2022 - 11/2007
24Neutropenia
01/2021 - 12/2012
21Disease Progression
01/2022 - 01/2012
16Colorectal Neoplasms (Colorectal Cancer)
12/2016 - 06/2005
16Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2014 - 01/2005
13Adenocarcinoma
01/2016 - 11/2004
10Biliary Tract Neoplasms (Biliary Tract Cancer)
10/2017 - 12/2008
9Vomiting
01/2022 - 12/2004
9Nausea
01/2022 - 02/2009
9Pancreatic Neoplasms (Pancreatic Cancer)
10/2021 - 10/2011
9Hepatocellular Carcinoma (Hepatoma)
01/2021 - 12/2005
7Pathologic Complete Response
01/2022 - 12/2012
7Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor)
01/2022 - 09/2011
7Febrile Neutropenia
01/2021 - 01/2012
7Lymphatic Metastasis
08/2016 - 06/2005
6Diarrhea
11/2020 - 01/2012
6Leukopenia
01/2019 - 11/2016
5Carcinoma (Carcinomatosis)
01/2022 - 11/2004
5Brain Neoplasms (Brain Tumor)
12/2021 - 01/2017
5Ataxia Telangiectasia (Louis Bar Syndrome)
12/2017 - 01/2014
5Colonic Neoplasms (Colon Cancer)
05/2013 - 10/2011
4Thrombocytopenia (Thrombopenia)
01/2022 - 07/2016
4Pneumonia (Pneumonitis)
01/2022 - 12/2013
4Exanthema (Rash)
07/2021 - 10/2016
4Stomatitis
07/2021 - 02/2012

Drug/Important Bio-Agent (IBA)

59Hormones (Hormone)IBA
10/2022 - 02/2010
40ErbB Receptors (EGF Receptor)IBA
10/2022 - 01/2005
40Trastuzumab (Herceptin)FDA Link
10/2022 - 01/2008
34human ERBB2 proteinIBA
10/2022 - 10/2008
28Biomarkers (Surrogate Marker)IBA
04/2022 - 07/2011
28Fluorouracil (Carac)FDA LinkGeneric
10/2021 - 06/2005
25taxaneIBA
10/2022 - 06/2008
25Docetaxel (Taxotere)FDA Link
02/2022 - 11/2007
25Estrogen ReceptorsIBA
01/2022 - 10/2008
24Paclitaxel (Taxol)FDA LinkGeneric
10/2022 - 11/2004
23Proteins (Proteins, Gene)FDA Link
11/2020 - 06/2005
20GemcitabineFDA Link
01/2022 - 06/2006
19AnthracyclinesIBA
10/2022 - 08/2005
17Doxorubicin (Adriamycin)FDA LinkGeneric
10/2022 - 07/2006
17palbociclibIBA
04/2022 - 04/2016
17Capecitabine (Xeloda)FDA Link
04/2022 - 01/2011
17Cisplatin (Platino)FDA LinkGeneric
10/2021 - 11/2004
14Pharmaceutical PreparationsIBA
04/2022 - 10/2007
14Fulvestrant (Faslodex)FDA Link
01/2022 - 04/2016
13Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2022 - 09/2005
13Oxaliplatin (Eloxatin)FDA LinkGeneric
10/2021 - 05/2008
12pertuzumabIBA
10/2022 - 01/2012
11Lapatinib (GW572016)FDA Link
01/2021 - 03/2008
11olaparibIBA
02/2020 - 06/2013
10Biological ProductsIBA
01/2020 - 07/2006
9PlatinumIBA
10/2021 - 07/2006
9TamoxifenFDA LinkGeneric
07/2021 - 07/2012
9DNA (Deoxyribonucleic Acid)IBA
01/2020 - 12/2005
9Tyrosine Kinase InhibitorsIBA
07/2018 - 03/2008
9Gefitinib (Iressa)FDA Link
02/2012 - 01/2005
8ribociclibIBA
03/2022 - 01/2018
8Aromatase InhibitorsIBA
01/2021 - 07/2012
8Leucovorin (Folinic Acid)FDA Link
07/2016 - 05/2008
7Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2021 - 06/2013
7Phenobarbital (Luminal)FDA Link
05/2019 - 01/2013
7Epidermal Growth Factor (EGF)IBA
01/2019 - 11/2006
7Irinotecan (Camptosar)FDA LinkGeneric
01/2019 - 09/2008
6exemestane (Aromasin)FDA Link
07/2021 - 03/2013
6HM781-36BIBA
12/2020 - 03/2011
6Letrozole (Femara)FDA LinkGeneric
01/2020 - 01/2014
6Imatinib Mesylate (Gleevec)FDA Link
04/2017 - 09/2011
6Progesterone Receptors (Progesterone Receptor)IBA
06/2016 - 10/2008
6Cetuximab (Erbitux)FDA Link
01/2013 - 03/2008
5Taxoids (Taxanes)IBA
10/2022 - 08/2005
5Ado-Trastuzumab EmtansineIBA
10/2022 - 12/2018
5Monoclonal AntibodiesIBA
01/2022 - 11/2005
5Gonadotropin-Releasing Hormone (GnRH)FDA Link
11/2020 - 01/2017
5Vinorelbine (Navelbine)FDA LinkGeneric
12/2019 - 06/2008
5eribulinFDA Link
11/2019 - 04/2017
5thiamine triphosphorate (TTP)IBA
11/2018 - 08/2010
5etirinotecan pegolIBA
01/2018 - 11/2015
5Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2018 - 05/2011
5Sunitinib (Sutent)FDA Link
04/2017 - 07/2011
5Bevacizumab (Avastin)FDA Link
01/2017 - 12/2012
5Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
01/2017 - 09/2011
4pembrolizumabIBA
10/2022 - 01/2018
4130-nm albumin-bound paclitaxelIBA
04/2022 - 09/2017
4atezolizumabIBA
01/2022 - 11/2018
4trastuzumab deruxtecanIBA
01/2022 - 01/2020
4Aspartate Aminotransferases (Aspartate Transaminase)IBA
07/2021 - 01/2017
4Alanine Transaminase (SGPT)IBA
07/2021 - 01/2017

Therapy/Procedure

133Drug Therapy (Chemotherapy)
10/2022 - 11/2004
101Therapeutics
10/2022 - 12/2005
43Neoadjuvant Therapy
10/2022 - 11/2007
27Adjuvant Chemotherapy
02/2022 - 12/2004
23Radiotherapy
04/2022 - 07/2006
13Combination Drug Therapy (Combination Chemotherapy)
11/2017 - 11/2004
12Adjuvant Chemoradiotherapy
04/2017 - 02/2009
8Chemoradiotherapy
10/2021 - 02/2009
7Segmental Mastectomy (Lumpectomy)
12/2016 - 06/2005
4Aftercare (After-Treatment)
01/2022 - 01/2018